Tweenvest Stocks

Shandong Boan Biotechnology Co., Ltd. (SEHK: 6955)

Health Care · Biotechnology · CN

HK$4.31

-5.90% today · -72.4% 1Y

Shandong Boan Biotechnology Co., Ltd. (SEHK: 6955) operates in the Biotechnology industry within the Health Care sector. The company is valued at $342.12M and employs 696 people.

Over the last twelve months the share price has lost 72.4%, trading between 4.11 and 16.52.

Tweenvest scores Shandong Boan Biotechnology Co., Ltd. across four factors: quality 58/100, value 44/100. Its strongest factor is quality.

6955 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$342.12M
Revenue (TTM)
$112.21M
P/E
EPS
0.01
Dividend yield
Beta (5Y)
0.05
52-week high
HK$16.52
52-week low
HK$4.11
Avg volume (3M)
Shares outstanding
622.33M
Employees
696
Next earnings

About Shandong Boan Biotechnology Co., Ltd.

Shandong Boan Biotechnology Co., Ltd. is a biopharmaceutical company, which engages in therapeutic antibody development, manufacturing and commercialization. It operates through the Mainland China and Other countries geographical segments. It focuses on key therapeutic areas including oncology, metabolism, autoimmunity, and ophthalmology. The company was founded on December 30, 2013 and is headquartered in Yantai, China.

ISIN
CNE100005RV4
Founded
2013
Listed since
Dec 29, 2022
Exchange
The Stock Exchange of Hong Kong Ltd.
Currency
HKD
CompanyMarket capPriceDay
AbbVie Inc.NYSE: ABBV$467.44B$264.52-0.17%
Amgen Inc.NasdaqGS: AMGN$239.95B$443.84+1.03%
Gilead Sciences, Inc.NasdaqGS: GILD$181.95B$146.74+0.42%
Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX$138.79B$547.59-0.08%
Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN$82.73B$828.50-0.66%
argenx SEENXTBR: ARGX$63.06B874.20+1.16%
CSL LimitedASX: CSL$57.94BAU$169.11+0.48%
Moderna, Inc.NasdaqGS: MRNA$55.45B$141.77+2.07%

Browse every Biotechnology company →

Figures last refreshed Aug 18, 2026.